CClinicalTrials.gg
CompletedNCT04548947Updated Dec 8, 2022

Does Routine Submucosal Injection Improve Complete Resection of 4-20 mm Neoplastic Colorectal Polyps?

An interventional study of Cold snare polypectomy in conjunction with a submucosal injection in Colorectal Cancer, sponsored by Centre hospitalier de l'Université de Montréal (CHUM). Completed at 1 site in Canada. Open to participants aged 45 Years to 80 Years. Per ClinicalTrials.gov, last updated 2022-12-08.

Sponsored by Centre hospitalier de l'Université de Montréal (CHUM) · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
429
Allocation
Not applicable
Ages
45 Years to 80 Years
Sex
All
01

Study summary

This is a prospective, multi-endoscopist, single center, clinical study at tertiary referral center that addresses an important current challenge in the prevention of colorectal cancer (CRC), namely, how to improve the complete removal of CRC precursors. This study will observe the potential benefit of specific polypectomy technique in conjunction with a systematic submucosal injection prior to the polyp resection. This study will evaluate the completeness and incompleteness of the resection of colorectal neoplastic polyps during the procedures.

Read the detailed description

Non-detection and incomplete resection of neoplastic colorectal polyps have been identified as the main risk factors for the development of CRC in patients after a colonoscopy. Between 7% and 9% of all newly diagnosed CRCs are estimated to be such "interval cancers," occurring after a previous colonoscopy and before the next surveillance examination. The vast majority of interval cancers are caused by incomplete detection or resection during colonoscopy examination. The contribution of incomplete resection towards interval cancer has recently been pointed out by a panel of experts as one of the cornerstones of CRC prevention that need to be addressed in future research studies. The primary aim of this study is to examine the incomplete adenoma resection rates when performing a cold snare polypectomy in conjunction with a submucosal injection for endoscopic resection of 4-20 mm non-pedunculated colorectal polyps. The subjects are patients, men and women, aged between 45-80 years old that are scheduled for a colonoscopy. The secondary aims are to identify procedure-related complication rates and patient-, polyp-, and endoscopist-related factors associated with incomplete adenoma resection.

02

Conditions studied

  • Colorectal Cancer

Keywords

  • colorectal cancer
  • incomplete resection rate
  • submucosal injection
  • neoplastic polyps
03

In context

Colorectal Neoplasms

5,599 studies on the registry are indexed under Colorectal Neoplasms; 1,459 are open to participants now.

This study's enrollment of 429 is above the median of 77 across 4,123 interventional studies indexed under Colorectal Neoplasms.

Browse Colorectal Neoplasms studies →

Lead sponsor

Centre hospitalier de l'Université de Montréal (CHUM) is the lead sponsor of 370 studies on the registry; 110 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Signed consent form; aged 45-80 years old, indication to undergo a colonoscopy

Exclusion criteria

Exclusion Criteria:

  • Known inflammatory bowel disease; active colitis; coagulopathy; familial polyposis syndrome; poor general health, defined as an American Society of Anesthesiologists (ASA) physical status class >3; emergency colonoscopies, hospitalized patients or patients referred from the emergency room.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
429 participants (actual)

Study arms

  • Experimental
    Cold snare polypectomy with a submucosal injection

    The procedure will include a cold snare polypectomy with a submucosal injection done prior to the resection.

    Procedure: Cold snare polypectomy in conjunction with a submucosal injection

Interventions

  • ProcedureCold snare polypectomy in conjunction with a submucosal injection

    The cold snare polypectomy in conjunction with a submucosal injection is a procedure during which the endoscopist resects the colorectal polyps during a colonoscopy, without any electrocautery.

06

What researchers measure

Primary outcomes

  1. Incomplete resection rate (IRR)

    The number of incomplete polyps resected after polypectomy, as defined by any neoplastic tissue found in marginal biopsies.

    Time frame: Day 1

Secondary outcomes

  1. Immediate bleeding complications

    bleeding requiring endoscopic intervention either during colonoscopy/polypectomy, or requiring an immediate second intervention such as surgery and/or hospital admission

    Time frame: Day 1

  2. Delayed bleeding complications

    bleeding after the end of the initial procedure 14 days later

    Time frame: 14 days after the initial procedure

  3. Other severe complications

    Post-polypectomy syndrome and perforation requiring endoscopic intervention and/or surgery, and/or hospital admission

    Time frame: 14 days after the initial procedure

  4. Proportion of polyps considered interpretable for complete polyp removal

    Proportion of polyps considered interpretable for complete polyp removal

    Time frame: 14 days after the initial procedure

  5. Incomplete resection of colorectal polyps

    Incomplete resection rates of colorectal polyps after widefield resection (defined as resection margins of the largest of 3mm or 25% of the resected polyp size) of 1-20mm polyps using SCALE-EYE as measurement tool vs standard non wide field polypectomy (defined by positive tissue remnants at biopsy sites \[vertical and lateral margins, 4 biopsies\])

    Time frame: 14 days after the initial procedure

07

Study locations

1 site
  • Centre Hospitalier Universitaire de Montréal
    Montréal, Quebec, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 8, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04548947
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Responsible party
Sponsor
First posted
Sep 16, 2020
Start date
Jan 12, 2021
Primary completion
Oct 1, 2021
Completion
Jul 1, 2022
Last update
Dec 8, 2022

Study contacts

Daniel von Renteln, MD
principal investigator · Centre hospitalier de l'Université de Montréal (CHUM)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion